<?xml version="1.0" encoding="UTF-8"?>
<AssessmentQuestion xmlns="http://soap.sforce.com/2006/04/metadata">
    <assessmentQuestionVersion>
        <isActive>true</isActive>
        <name>Pegcetacoplan Initial Initiation Q26</name>
        <optionSourceResponseValue>false</optionSourceResponseValue>
        <questionText>3. Patient experiences persistent anemia with hemoglobin levels &lt;10.5 g/dL despite an adequate trial of eculizumab where causes other than extravascular hemolysis have been excluded or the patient has intolerable adverse events from eculizumab.</questionText>
        <responseValues>Yes
No</responseValues>
        <status>Active</status>
        <versionNumber>1</versionNumber>
    </assessmentQuestionVersion>
    <dataType>Radio</dataType>
    <developerName>Pegcetacoplan_Initial_Initiation_Q26</developerName>
    <name>Pegcetacoplan Initial Initiation Q26</name>
    <questionCategory>Demographic</questionCategory>
</AssessmentQuestion>
